Therapeutics: Cathepsin B; cathepsin L (CTSL); α-synuclein (SNCA)

Neurology

INDICATION: Parkinson's disease (PD)

In vitro studies suggest activating cathepsin L and

Read the full 115 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE